Value proposition

Analytical CRO devoted to bioanalysis and quality control of small molecules, biologics and nucleic acids

Kymos is a CRO that provides development services for pharmaceutical, biotechnology, veterinary, fine chemistry, cosmetics and nutraceuticals industries. The main areas of activity are the following ones:
i) Immunogenicity studies and immunoassay of innovative biological drugs, biosimilars and vaccines.
ii) Bioanalysis in preclinical and clinical studies, including full bioequivalence studies.
iii) Quality control, stability studies and analytical development of drug substances and drug products (physico-chemical and microbiological testing)
iv) Process analytical technology services, using NIR and RAMAN and QbD strategies.
Kymos is certified in GLP's and GMP's compliance and it has been authorized as partial manufacturer in quality control.

Bioanalysis of preclinical and clinical studies, Quality Control of ingredients and products, Batch release certifications, Pharmaceutical development, Immunogenicity, Immunoassay, and Bioequivalence studies